脓毒性休克患者左心室舒张功能不全相关因素分析及其预后影响

doi:10.3877/cma.j.issn.1674-6880.2017.02.005

中华危重症医学杂志(电子版) ›› 2017, Vol. 10 ›› Issue (02) : 92 -97. doi: 10.3877/cma.j.issn.1674-6880.2017.02.005

所属专题：文献；

论著

脓毒性休克患者左心室舒张功能不全相关因素分析及其预后影响

呼邦传¹^,^†(

), 王宇佳¹, 葛伟东², 李锋之², 孙仁华¹

^1. 310014　杭州，浙江省人民医院重症医学科
^2. 310014　杭州，浙江省人民医院超声科

收稿日期:2016-10-26 出版日期:2017-04-01
通信作者: 呼邦传
基金资助:
浙江省公益性技术应用研究项目(2014C37023); 浙江省自然科学基金项目(LY17H15000); 浙江省医药卫生平台骨干项目(2013RCB001)

Analysis on correlation factors of left ventricular diastolic dysfunction and its association with mortality in the patients with septic shock

Bangchuan Hu¹^,^†(), Yujia Wang¹, Weidong Ge², Fengzhi Li², Renhua Sun¹

^1. Department of Intensive Care Unit, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China
^2. Department of Ultrasonography, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China

Received:2016-10-26 Published:2017-04-01
Corresponding author: Bangchuan Hu
About author:
Corresponding author: Hu Bangchuan, Email: hubangchuanicu@163.com

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

呼邦传, 王宇佳, 葛伟东, 李锋之, 孙仁华. 脓毒性休克患者左心室舒张功能不全相关因素分析及其预后影响[J]. 中华危重症医学杂志(电子版), 2017, 10(02): 92-97.

Bangchuan Hu, Yujia Wang, Weidong Ge, Fengzhi Li, Renhua Sun. Analysis on correlation factors of left ventricular diastolic dysfunction and its association with mortality in the patients with septic shock[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2017, 10(02): 92-97.

目的

探讨影响脓毒性休克患者左心室舒张功能不全（LVDD）的相关因素及其对临床预后影响。

方法

选取2014年6月至2015年12月浙江省人民医院ICU收治的127例脓毒性休克患者，按照舒张功能分为LVDD组（49例）和对照组（78例），对照组为左心室舒张功能正常患者。对两组患者的一般资料进行比较。于入ICU 24 h内行超声心动图检查，结合二尖瓣环舒张早期运动速度峰值（E’）和二尖瓣舒张早期血流速峰值/二尖瓣环舒张早期运动速度峰值比率（E/E’）作为评价脓毒性休克患者LVDD的指标。运用Pearson简单相关分析探讨影响脓毒性休克患者LVDD的相关因素，采用多元Logistic回归分析脓毒性休克患者死亡的危险因素。

结果

两组患者在年龄[（63 ± 14）岁vs.（58 ± 18）岁]、入ICU时收缩压[（90 ± 18）mmHg vs.（99 ± 18）mmHg]、冠状动脉粥样硬化性心脏病（CHD）（15/49 vs. 12/78）、血肌酐[（188 ± 96）μmol/L vs.（116 ± 92）μmol/L]、急性病生理学与长期健康状况评价（APACHE）Ⅱ评分[（21 ± 5）分vs.（17 ± 6）分]、血浆脑利钠肽（BNP）[（178 ± 84）pg/mL vs.（355 ± 128）pg/mL]、左室收缩末期内径（LVESD）[（34 ± 8）mm vs.（31 ± 5）mm]、室间隔厚度（IVST）[（10.1 ± 1.9）mm vs.（9.4 ± 1.4）mm]、左室后壁厚度（PWT）[（10.2 ± 1.5）mm vs.（9.6 ± 1.2）mm]、左室侧壁二尖瓣环收缩期运动速度峰值（S’）[（9.0 ± 3.0）cm/s vs.（11.4 ± 3.6）cm/s]、E’[（7.3 ± 2.3）cm/s vs.（12.3 ± 3.6）cm/s]及E/E’[（11.6 ± 4.0）vs.（6.8 ± 2.6）]方面比较，差异均有统计学意义（P均< 0.05）。相关分析显示：年龄、高血压、CHD、血浆BNP和APACHEⅡ评分与E/E’呈正相关（r = 0.302、0.289、0.277、0.418、0.290，P均< 0.05）；而入ICU收缩压和左室射血分数（LVEF）与E/E’呈负相关（r = -0.239、-0.284，P均< 0.05）。多元Logistic回归分析统计结果显示：年龄[OR = 1.040，95%CI（1.020，1.071）]、血乳酸[OR = 1.492，95%CI（1.176，1.732）]、血浆BNP [OR = 2.051，95% CI（1.232，2.964）]、E/E’ [OR = 1.362，95% CI（1.122，1.534）]和APACHEⅡ评分[OR = 2.370，95%CI（1.131，3.674）]是预测脓毒性休克患者死亡的独立危险因素（P均< 0.05）。

结论

年龄、入ICU收缩压、高血压、冠状动脉粥样硬化性心脏病、血浆BNP、APACHEⅡ评分和LVEF与脓毒性休克患者LVDD存在相关；而年龄、血乳酸、血浆BNP、E/E’和APACHEⅡ评分是脓毒性休克患者死亡的独立危险因素。

关键词: 脓毒性休克, 左心室舒张功能不全, B型脑利钠肽, 预后

Objective

To study the determinants of left ventricular diastolic dysfunction (LVDD) and investigate its association with mortality in patients with septic shock.

Methods

Totally 127 patients with septic shock in Zhejiang Provincial People’s Hospital recruited from June 2014 to December 2015 were divided into the LVDD group (49 cases) and control group as patients with normal left ventricular diastolic function (78 cases). General data of the two groups were compared. According to diastolic function underwent trans-thoracic echocardiography examination within 24 h after admission to ICU, LVDD was assessed as the conbination early diastolic mitral annulus velocity (E’) with the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/E’). The related factors of LVDD in patients with septic shock were analyzed by Pearson simple correlation, and the risk factors associated with mortality in patients with septic shock were evaluated by multivariate Logistic regression.

Results

Compared with the normal group, the age [(63 ± 14) years vs. (58 ± 18) years], systolic blood pressure admitted to ICU [(90 ± 18) mmHg vs. (99 ± 18) mmHg], coronary atherosclerotic heart disease (CHD) (15/49 vs. 12/78), serum creatinine [(188 ± 96) μmol/L vs. (116 ± 92) μmol/L], acute physiology and chronic health evaluation (APACHE) Ⅱ scores [(21 ± 5) vs. (17 ± 6)], plasma brain natriuretic peptide (BNP) [(178 ± 84) pg/mL vs. (355 ± 128) pg/mL], left ventricular end systolic diamete (LVESD) [(34 ± 8) mm vs. (31 ± 5) mm], interventricular septal thickness (IVST) [(10.1 ± 1.9) mm vs. (9.4 ± 1.4) mm], left ventricular posterior wall thickness (PWT) [(10.2 ± 1.5) mm vs. (9.6 ± 1.2) mm], mitral annular systolic velocity peak (S’) [(9.0 ± 3.0) cm/s vs. (11.4 ± 3.6) cm/s], E’[(7.3 ± 2.3) cm/s vs. (12.3 ± 3.6) cm/s] and E/E’[(11.6 ± 4.0) vs. (6.8 ± 2.6)] of these two groups were significantly different (all P < 0.05). Correlation analysis showed that E/E’ had a positive correlation with age, hypertension, CHD, plasma BNP and APACHEⅡ score (r = 0.302, 0.289, 0.277, 0.418, 0.290; all P < 0.05). However, the systolic blood pressure admitted to ICU and left ventricular eject fraction (LVEF) had negative correlations with those parameters (r = -0.239, -0.284; all P < 0.05). Multivariate Logistic regression analysis found that age [OR = 1.040, 95% CI (1.020, 1.071)], blood lactic acid [OR = 1.492, 95% CI (1.176, 1.732)], plasma BNP [OR = 2.051, 95% CI (1.232, 2.964)], E/E’ [OR = 1.362, 95% CI (1.122, 1.534)] and APACHE Ⅱ score [OR = 2.370, 95% CI (1.131, 3.674)] were the independent risk factors associated with mortality in patients with septic shock (all P < 0.05).

Conclusions

Age, systolic blood pressure admitted to ICU, hypertension, CHD, plasma BNP, APACHEⅡ score and LVEF were significantly related to LVDD. However, age, blood lactic acid, plasma BNP, E/E’and APACHE Ⅱ score were the independent risk factors associated with mortality in patients with septic shock.

Key words: Septic shock, Left ventricular diastolic dysfunction, B-type brain natriuretic peptide, Prognosis

表1 两组脓毒性休克患者一般资料比较（ ± s）

组别	例数	入ICU收缩压（mmHg）	入ICU舒张压（mmHg）	血糖（mmol/L）	白蛋白（g/L）	血乳酸（mmol/L）
LVDD组	49	90 ± 18	57 ± 16	9.2 ± 1.6	32 ± 4	2.9 ± 1.3
对照组	78	99 ± 18	60 ± 14	9.0 ± 1.4	32 ± 6	2.8 ± 1.8
t/χ²值	?	2.633	1.269	0.441	0.132	0.247
P值	?	0.024	0.197	0.632	0.922	0.787
组别	例数	血肌酐（μmol/L）	APACHEⅡ评分（分）	肌钙蛋白I（ng/mL）	血浆BNP（pg/mL）	血管活性药物使用（例，%）
LVDD组	49	188 ± 96	21 ± 5	0.7 ± 1.6	355 ± 128	45（91.8%）
对照组	78	116 ± 92	17 ± 6	0.5 ± 1.6	178 ± 84	69（88.5%）
t/χ²值	?	3.819	4.558	0.653	5.848	0.371
P值	?	< 0.001	< 0.001	0.523	< 0.001	0.542

表1 两组脓毒性休克患者一般资料比较（ ± s）

组别	例数	入ICU收缩压（mmHg）	入ICU舒张压（mmHg）	血糖（mmol/L）	白蛋白（g/L）	血乳酸（mmol/L）
LVDD组	49	90 ± 18	57 ± 16	9.2 ± 1.6	32 ± 4	2.9 ± 1.3
对照组	78	99 ± 18	60 ± 14	9.0 ± 1.4	32 ± 6	2.8 ± 1.8
t/χ²值	?	2.633	1.269	0.441	0.132	0.247
P值	?	0.024	0.197	0.632	0.922	0.787
组别	例数	血肌酐（μmol/L）	APACHEⅡ评分（分）	肌钙蛋白I（ng/mL）	血浆BNP（pg/mL）	血管活性药物使用（例，%）
LVDD组	49	188 ± 96	21 ± 5	0.7 ± 1.6	355 ± 128	45（91.8%）
对照组	78	116 ± 92	17 ± 6	0.5 ± 1.6	178 ± 84	69（88.5%）
t/χ²值	?	3.819	4.558	0.653	5.848	0.371
P值	?	< 0.001	< 0.001	0.523	< 0.001	0.542

表2 两组脓毒性休克患者心脏超声资料比较（ ± s）

组别	例数	LVEDD（mm）	LVESD（mm）	IVST（mm）	PWT（mm）	LVEF（分）	E（m/s）
LVDD组	49	50 ± 7	34 ± 8	10.1 ± 1.9	10.2 ± 1.5	53 ± 14	0.85 ± 0.30
对照组	78	49 ± 6	31 ± 5	9.4 ± 1.4	9.6 ± 1.2	55 ± 10	0.84 ± 0.22
t/χ²值	?	1.123	2.459	2.782	2.374	0.830	0.292
P值	?	0.276	0.032	0.025	0.037	0.326	0.734
组别	例数	A（m/s）	E/A	DT（m/s）	S’（cm/s）	E’（cm/s）	E/E’
LVDD组	49	0.84 ± 0.32	1.1 ± 0.6	134 ± 57	9.0 ± 3.0	7.3 ± 2.3	11.6 ± 4.0
对照组	78	0.77 ± 0.21	1.1 ± 0.4	146 ± 54	11.4 ± 3.6	12.3 ± 3.6	6.8 ± 2.6
t/χ²值	?	1.353	0.618	0.865	3.948	6.786	5.320
P值	?	0.201	0.553	0.302	< 0.001	< 0.001	< 0.001

表2 两组脓毒性休克患者心脏超声资料比较（ ± s）

组别	例数	LVEDD（mm）	LVESD（mm）	IVST（mm）	PWT（mm）	LVEF（分）	E（m/s）
LVDD组	49	50 ± 7	34 ± 8	10.1 ± 1.9	10.2 ± 1.5	53 ± 14	0.85 ± 0.30
对照组	78	49 ± 6	31 ± 5	9.4 ± 1.4	9.6 ± 1.2	55 ± 10	0.84 ± 0.22
t/χ²值	?	1.123	2.459	2.782	2.374	0.830	0.292
P值	?	0.276	0.032	0.025	0.037	0.326	0.734
组别	例数	A（m/s）	E/A	DT（m/s）	S’（cm/s）	E’（cm/s）	E/E’
LVDD组	49	0.84 ± 0.32	1.1 ± 0.6	134 ± 57	9.0 ± 3.0	7.3 ± 2.3	11.6 ± 4.0
对照组	78	0.77 ± 0.21	1.1 ± 0.4	146 ± 54	11.4 ± 3.6	12.3 ± 3.6	6.8 ± 2.6
t/χ²值	?	1.353	0.618	0.865	3.948	6.786	5.320
P值	?	0.201	0.553	0.302	< 0.001	< 0.001	< 0.001

表3 Logistic回归评价脓毒性休克死亡危险因素

指标	回归系数	标准误	OR值	95%CI	Wald值	P值
年龄（岁）	0.041	0.030	1.040	1.020 ~ 1.071	5.631	0.022
血乳酸（mmol/L）	0.202	0.123	1.492	1.176 ~ 1.732	4.894	0.032
血浆BNP（ng/L）	0.289	0.103	2.051	1.232 ~ 2.964	8.569	0.007
E/E’	0.151	0.053	1.362	1.122 ~ 1.534	3.980	0.043
APACHEⅡ评分（分）	0.318	0.116	2.370	1.131 ~ 3.674	10.52	0.001

表3 Logistic回归评价脓毒性休克死亡危险因素

指标	回归系数	标准误	OR值	95%CI	Wald值	P值
年龄（岁）	0.041	0.030	1.040	1.020 ~ 1.071	5.631	0.022
血乳酸（mmol/L）	0.202	0.123	1.492	1.176 ~ 1.732	4.894	0.032
血浆BNP（ng/L）	0.289	0.103	2.051	1.232 ~ 2.964	8.569	0.007
E/E’	0.151	0.053	1.362	1.122 ~ 1.534	3.980	0.043
APACHEⅡ评分（分）	0.318	0.116	2.370	1.131 ~ 3.674	10.52	0.001

1	Pulido JN, Afessa B, Masaki M, et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock[J]. Mayo Clin Proc, 2012, 87 (7): 620-628.
2	赖志珍，孟建标，胡马洪，等. 左西孟旦对脓毒性休克患者血流动力学及心肌损伤标志物的影响[J/CD]. 中华危重症医学杂志（电子版），2016，9(3):163-168.
3	Acil T, Wichter T, Stypmann J, et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure[J]. Int J Cardiol, 2005, 103 (2): 175-181.
4	Lee CH, Hung KC, Chang SH, et al. Reversible left ventricular diastolic dysfunction on Doppler tissue imaging predicts a more favorable prognosis in chronic heart failure[J]. Circ J, 2012, 76 (5): 1145-1150.
5	Sturgess DJ, Marwick TH, Joyce C, et al. Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers[J]. Crit Care, 2010, 14 (2): R44.
6	Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock[J]. Eur Heart J, 2012, 33 (7): 895-903.
7	Brown SM, Pittman JE, Hirshberg EL, et al. Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study[J]. Crit Ultrasound J, 2012, 4 (1): 8.
8	Lim HS, Kang SJ, Choi JH, et al. Is E/E' reliable in patients with regional wall motion abnormalities to estimate left ventricular filling pressure[J]. Int J Cardiovasc Imaging, 2009, 25 (1): 33-39.
9	Grewal J, McKelvie R, Lonn E, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction[J]. Eur J Heart Fail, 2008, 10 (3): 252-259.
10	AlJaroudi WA, Thomas JD, Rodriguez LL, et al. Prognostic value of diastolic dysfunction: state of the art review[J]. Cardiol Rev, 2014, 22 (2): 79-90.
11	Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41 (2): 580-637.
12	Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heartfailure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology[J]. Eur Heart J, 2007, 28 (20): 2539-2550.
13	Borlaug BA, Lam CS, Roger VL, et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction[J]. J Am Coll Cardiol, 2009, 54 (5): 410-418.
14	Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study[J]. N Engl J Med, 2006, 355 (3): 260-269.
15	Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters[J]. Circulation. 2004, 109 (20): 2432-2439.
16	Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden[J]. Am J Cardiol, 2002, 90 (12): 1284-1289.
17	Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study[J]. J Am Coll Cardiol, 2005, 45 (1): 87-92.
18	Noh JH, Doh JH, Lee SY, et al. Risk factors associated with left ventricular diastolic dysfunction in type 2 diabetic patients without hypertension[J]. Korean Diabetes J, 2010, 34 (1): 40-46.
19	AlJaroudi W, Alraies MC, Halley CM, et al. Incremental prognostic value of isolated diastolic dysfunction in healthy patients: beyond framingham risk score[J]. Eur Heart J, 2012, 33 (suppl 1): 339-653.
20	Mak GS, DeMaria A, Clopton P, et al. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings[J]. Am Heart J, 2004, 148 (5): 895-902.
21	Grewal J, McKelvie RS, Persson H, et al. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction[J]. Am J Cardiol, 2008, 102 (6): 733-737.
22	Ikonomidis I, Nikolaou M, Dimopoulou I, et al. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome[J]. Shock, 2010, 33 (2): 141-148.
23	Antonucci E, Fiaccadori E, Donadello K, et al. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment[J]. J Crit Care, 2014, 29 (4): 500-511.
24	Sanfilippo F, Corredor C, Fletcher N, et al. Diastolic dysfunction and mortality in septic patients:a systematic review and meta-analysis[J]. Intensive Care Med, 2015, 41 (6): 1004-1013.

[1]	衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2]	施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[3]	谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[4]	张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[5]	杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6]	栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7]	马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8]	江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[9]	晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[10]	钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[11]	胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[12]	陆萍, 邹健. 凝血和纤维蛋白溶解标志物的动态变化对急性胰腺炎患者预后的评估价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 427-432.
[13]	李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14]	王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15]	索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Analysis on correlation factors of left ventricular diastolic dysfunction and its association with mortality in the patients with septic shock

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Analysis on correlation factors of left ventricular diastolic dysfunction and its association with mortality in the patients with septic shock